PULSION Medical Systems SE engages in the development, manufacture, and distribution of monitoring, diagnosis, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include PiCCO platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex that offers technology in the field of perioperative medicine; PiCCO catheter used to monitor the cardiovascular system; ProAQT, a sensor used in medicine for high-risk patients and high-risk interventions; CeVOX, a technology that enables continuous monitoring of the patient's oxygen balance; LiMON, a technology used to assess and monitor liver function; and NICCI for hemodynamic monitoring. The company was founded in 1990 and is based in Feldkirchen, Germany.